Pre-existing risk factors for gallstone disease include: Female sex : Women are two to three times more likely to develop gallstones than men, particularly during reproductive years due to hormonal influences Age over 40 years : Gallstone prevalence increases progressively with age Obesity : Higher body mass index correlates with increased gallstone risk, creating a paradox where the condition being treated is itself a risk factor Rapid weight loss history : Previous episodes of quick weight reduction may indicate susceptibility Pregnancy or recent pregnancy : Hormonal changes affect bile composition and gallbladder motility Family history : Genetic factors contribute to gallstone formation Certain ethnicities : Native American and Hispanic populations have higher gallstone prevalence Metabolic syndrome and diabetes : These conditions are associated with altered bile metabolism The rate and magnitude of weight loss during semaglutide treatment significantly influence gallbladder complication risk
The right drug: not every weight-loss shot is the same Right now in the U.S., the main injectable medications approved by the FDA for chronic weight management are liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)
Weight Effects and Real-World Use Some patients observe modest appetite reduction over time
When patients understand what to expect, they can be more proactive and make wiser decisions
That option wont be available to athletes
By regulating blood sugar levels, they decrease hunger signals, control cravings, and prevent energy spikes and crashes, which can help you stick to a healthy eating plan
